Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

30.30INR
10:28am GMT
Change (% chg)

Rs-1.30 (-4.11%)
Prev Close
Rs31.60
Open
Rs31.60
Day's High
Rs31.60
Day's Low
Rs30.05
Volume
1,254,416
Avg. Vol
2,907,273
52-wk High
Rs50.35
52-wk Low
Rs23.55

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun 2,352.53 0.608
FY 2018 Mar '18 1,993.94 -0.168
Dec 2,184.34 0.410
Sep 2,738.09 0.230
Jun 2,210.56 0.333
FY 2017 Mar '17 1,847.49 -0.152
Dec 2,152.39 0.243
Sep 1,804.26 0.017
Jun 1,867.47 0.110
FY 2016 Mar '16 2,102.31 -0.140
Dec 2,174.07 0.440
Sep 2,555.30 0.852
Jun 2,101.59 0.769
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 2,320.50 2,393.00 2,248.00 --
Year Ending Mar-18 1 9,520.00 9,520.00 9,520.00 --
Year Ending Mar-19 1 10,893.00 10,893.00 10,893.00 11,764.00
Year Ending Mar-20 1 13,155.00 13,155.00 13,155.00 --
Earnings (per share)
Year Ending Mar-18 1 1.30 1.30 1.30 --
Year Ending Mar-19 1 1.20 1.20 1.20 2.95
Year Ending Mar-20 1 1.70 1.70 1.70 --
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 88.58 30.86 33.64
P/E High - Last 5 Yrs. 202.74 40.52 45.61
P/E Low - Last 5 Yrs. 3.32 23.24 23.70
Beta 1.92 0.89 0.88
Price to Sales (TTM) 2.45 4.02 5.95
Price to Book (MRQ) -- 4.77 4.89
Price to Tangible Book (MRQ) -- 5.60 6.50
Price to Cash Flow (TTM) 34.23 22.52 22.90
% Owned Institutions -- 1.13 2.15

Dividends

  Company industry sector
Dividend Yield 0.10 1.59 1.51
Dividend Yield - 5 Year Avg 0.21 1.59 1.52
Dividend 5 Year Growth Rate -- 4.42 5.41
Payout Ratio(TTM) 12.73 46.15 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 18.37 2.23 8.08
Sales (TTM) vs TTM 1 Yr. Ago -7.87 4.64 5.80
Sales - 5 Yr. Growth Rate 16.63 9.65 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago 202.90 19.34 23.27
EPS (TTM) vs TTM 1 Yr. Ago -57.13 -- --
EPS - 5 Yr. Growth Rate -- 9.95 10.88
Capital Spending - 5 Yr. Growth Rate 39.36 15.07 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.27
Current Ratio (MRQ) -- 2.99 3.07
LT Debt to Equity (MRQ) -- 10.29 13.15
Total Debt to Equity (MRQ) -- 14.52 17.74
Interest Coverage (TTM) 8.43 41.32 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 40.70 55.21 54.86
Gross Margin - 5 Yr. Avg. 38.62 52.32 52.38
EBITD Margin (TTM) 8.13 -- --
EBITD - 5 Yr. Avg 14.77 18.47 10.90
Operating Margin (TTM) 4.05 14.21 3.24
Operating Margin - 5 Yr. Avg. 11.77 14.35 6.22
Pre-Tax Margin (TTM) 4.12 14.75 4.31
Pre-Tax Margin - 5 Yr. Avg. 11.58 14.80 6.66
Net Profit Margin (TTM) 3.06 10.97 0.58
Net Profit Margin - 5 Yr. Avg. 9.34 11.07 2.90
Effective Tax Rate (TTM) 25.61 23.35 23.26
Effective Tax Rate - 5 Yr. Avg. 19.36 23.63 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) 11,178,110 905,167,346 803,310,395
Net Income/Employee (TTM) 342,558 106,519,628 94,478,415
Receivable Turnover (TTM) -- 5.61 5.78
Inventory Turnover (TTM) -- 2.61 3.71
Asset Turnover (TTM) -- 0.94 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.33 10.86
Return on Assets - 5 Yr. Avg. 11.52 12.57 11.96
Return on Investment (TTM) -- 14.72 14.22
Return on Investment - 5 Yr. Avg. 26.35 16.38 15.54
Return on Equity (TTM) -- 16.27 15.99
Return on Equity - 5 Yr. Avg. 27.24 17.46 16.82
  1 Year 3 Year 5 Year
Sales % -14.12 6.79 16.63
EPS (TTM) % -87.88 -50.08 --
Dividend % -58.33 -20.63 --
Note: Units in Millions of US Dollars

Performance for Marksans Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 21.88 21.40 99 22
13 Week 11.66 10.06 99 34
26 Week -8.15 -14.23 99 27
52 Week -14.00 -24.03 99 13
YTD 20.20 0.60 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.38%
# of Holders: 10
Total Shares Held: 13,840,507
3 Mo. Net Change: -2,935,648
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 3
# Reduced Positions: 4
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.